Combination drug targeting opioid system may help relieve treatment-resistant depression

(Massachusetts General Hospital) A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of serotonin and related monoamine neurotransmitters.